Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial

The aim of this study, using a Fleming single-stage design, was to explore the efficacy and safety of Taxotere® 100 mg m(−2) docetaxel and FEC 75 cyclophosphamide 500 mg m(−2), fluorouracil 500 mg m(−2) and epirubicin 75 mg m(−2), in alternating and sequential schedules for the first-line treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Spielmann, M, Tubiana-Hulin, M, Namer, M, Mansouri, H, Bougnoux, P h, Tubiana-Mathieu, N, Lotz, V, Eymard, J C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2002
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2375306/
https://ncbi.nlm.nih.gov/pubmed/11875727
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600165
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados